| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/17/2023 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 3.3k | $21.27 | $69.5k | | 01/17/2023 |
| 06/23/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 18.5k | $13.98 | $258.6k | | 06/23/2022 |
| 01/18/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 9.6k | $8.27 | $79.1k | | 01/18/2022 |
| 06/23/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $35.86 | $430.3k | | 06/23/2021 |
| 06/02/2021 | KINETA, INC./DE | PTI | Grant | Stock Option (Right to Buy) | 14.8k | $15.26 | $225.8k | | 06/02/2021 |
| 12/22/2020 | KINETA, INC./DE | PTI | Grant | Stock Option (Right to Buy) | 5.3k | $8.16 | $43k | | 12/22/2020 |
| 12/22/2020 | KINETA, INC./DE | PTI | Grant | Stock Option (Right to Buy) | 12.5k | $8.16 | $102k | | 12/22/2020 |
| 06/10/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $56.46 | $677.5k | | 06/10/2020 |
| 06/05/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 5.6k | $55.90 | $315k | | 06/03/2020 |
| 06/05/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 5.6k | $25.73 | $145k | | 06/03/2020 |
| 06/03/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 6.4k | $59.14 | $376.4k | | 06/03/2020 |
| 06/03/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 6.4k | $25.73 | $163.8k | | 06/03/2020 |
| 01/24/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 25k | $3.95 | $98.8k | | 01/24/2020 |
| 01/24/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 700 | $67.36 | $47.2k | | 01/24/2020 |
| 01/24/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 6.5k | $66.55 | $432.3k | | 01/24/2020 |
| 01/24/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 17.8k | $65.93 | $1.2M | | 01/24/2020 |
| 01/24/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Conversion | Common Stock | 25k | $3.95 | $98.8k | | 01/24/2020 |
| 06/11/2019 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $21.05 | $252.6k | | 06/11/2019 |
| 01/22/2019 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 125k | $4.63 | $578.8k | | 01/22/2019 |
| 05/17/2018 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $25.73 | $308.8k | | 05/17/2018 |
| 02/22/2018 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 125k | $7.77 | $971.2k | | 02/22/2018 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 6.2k | $3.95 | $24.6k | | 10/02/2017 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 35.2k | $3.95 | $139.2k | | 10/02/2017 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 1.3k | $6.13 | $7.8k | | 10/02/2017 |
| 10/02/2017 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to Buy) | 7.2k | $6.13 | $44k | | 10/02/2017 |
| 01/27/2017 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 88k | $4.05 | $356.4k | | 01/27/2017 |
| 07/26/2016 | Larimar Therapeutics, Inc. | ZFGN | Purchase | Common Stock | 8.2k | $3.15 | $25.8k | | 07/25/2016 |
| 07/25/2016 | Larimar Therapeutics, Inc. | ZFGN | Purchase | Common Stock | 7.8k | $3.08 | $24k | | 07/25/2016 |
| 03/31/2016 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 72k | $6.68 | $481k | | 03/31/2016 |
| 03/31/2016 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 36k | $6.68 | $240.5k | | 03/31/2016 |
| 02/27/2015 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 60k | $38.65 | $2.3M | | 02/27/2015 |
| 12/08/2010 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 25k | $9.14 | $228.5k | | 12/08/2010 |